Utility of Once-Daily Dose of Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism in Multisystem Trauma Patients
暂无分享,去创建一个
[1] A. Shillington,et al. Antithrombotic therapy practices in US hospitals in an era of practice guidelines. , 2005, Archives of internal medicine.
[2] T. Allen,et al. Retrievable vena cava filters in trauma patients for high-risk prophylaxis and prevention of pulmonary embolism. , 2005, American journal of surgery.
[3] Clifford W Colwell,et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[4] H. Yanar,et al. Venous Thromboembolism Prophylaxis after Head and Spinal Trauma: Intermittent Pneumatic Compression Devices Versus Low Molecular Weight Heparin , 2004, World Journal of Surgery.
[5] K. Seide,et al. Prevention of Thromboembolism with Low-Molecular-Weight Heparin in Orthopedic Surgery: A 5-Year Experience , 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[6] G. Velmahos,et al. Prevention of Venous Thromboembolism in the Acute Treatment Phase after Spinal Cord Injury: A Randomized, Multicenter Trial Comparing Low-Dose Heparin Plus Intermittent Pneumatic Compression with Enoxaparin , 2003 .
[7] G. Dervin,et al. Heparin prophylaxis for deep venous thrombosis in a patient with multiple injuries: an evidence-based approach to a clinical problem. , 2002, Canadian journal of surgery. Journal canadien de chirurgie.
[8] T. Ortel,et al. Issues in the utilization of low molecular weight heparins. , 2002, Seminars in hematology.
[9] M. Zuccarello,et al. Preliminary report on the safety of heparin for deep venous thrombosis prophylaxis after severe head injury. , 2002, The Journal of trauma.
[10] E. Guazzo,et al. Acute subdural haematomas and enoxaparin , 2002, Journal of Clinical Neuroscience.
[11] A. Turpie,et al. Review of enoxaparin and its clinical applications in venous and arterial thromboembolism , 2002, Expert opinion on pharmacotherapy.
[12] Elizabeth B. Seislove,et al. The role of surveillance duplex scanning in preventing venous thromboembolism in trauma patients. , 2002, The Journal of trauma.
[13] P. Kearney,et al. Enoxaparin treatment in high-risk trauma patients limits the utility of surveillance venous duplex scanning. , 2001, Journal of vascular surgery.
[14] D. Hak. Prevention of venous thromboembolism in trauma and long bone fractures , 2001, Current opinion in pulmonary medicine.
[15] G. Pineo,et al. Dalteparin sodium , 2001, Expert opinion on pharmacotherapy.
[16] S. Norwood,et al. A potentially expanded role for enoxaparin in preventing venous thromboembolism in high risk blunt trauma patients. , 2001, Journal of the American College of Surgeons.
[17] J. Heit,et al. Prevention of venous thromboembolism. , 2001, Clinics in geriatric medicine.
[18] S. Deitcher. Overview of enoxaparin in the treatment of deep vein thrombosis. , 2000, The American journal of managed care.
[19] P. Shekelle,et al. Prevention of venous thromboembolism after injury: an evidence-based report--part I: analysis of risk factors and evaluation of the role of vena caval filters. , 2000, Journal of Trauma.
[20] W. Vanderkolk,et al. Thrombosis risk in the trauma patient. Prevention and treatment. , 2000, Hematology/oncology clinics of North America.
[21] W. Casey,et al. Prophylactic inferior vena cava filters in trauma patients at high risk: follow-up examination and risk/benefit assessment. , 1999, Journal of vascular surgery.
[22] G. Wells,et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.
[23] M. Pasquale,et al. Practice management guidelines for trauma from the Eastern Association for the Surgery of Trauma. , 1998, The Journal of trauma.
[24] J. Szalai,et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. , 1996, The New England journal of medicine.
[25] M. Knudson,et al. Use of low molecular weight heparin in preventing thromboembolism in trauma patients. , 1996, The Journal of trauma.
[26] J. L. Rodriguez,et al. Early placement of prophylactic vena caval filters in injured patients at high risk for pulmonary embolism. , 1996, The Journal of trauma.
[27] H. Büller,et al. Low Molecular Weight Heparin and Compression Stockings in the Prevention of Venous Thromboembolism in Neurosurgery , 1996, Thrombosis and Haemostasis.
[28] C. Fisher,et al. Effectiveness of Pneumatic Leg Compression Devices for the Prevention of Thromboembolic Disease in Orthopaedic Trauma Patients: A Prospective, Randomized Study of Compression Alone Versus no Prophylaxis , 1995, Journal of orthopaedic trauma.
[29] J. Szalai,et al. A prospective study of venous thromboembolism after major trauma. , 1994, The New England journal of medicine.
[30] P. Levin. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. , 1994, The Journal of bone and joint surgery. American volume.
[31] S. Shackford,et al. Venous thromboembolism in patients with major trauma. , 1990, American journal of surgery.
[32] J. L. Rodriguez,et al. Posttrauma thromboembolism prophylaxis. , 1997, The Journal of trauma.
[33] G. Paiement,et al. The risk of venous thromboembolism in the orthopedic patient: epidemiological and physiological data. , 1997, Orthopedics.
[34] C. Colwell,et al. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group. , 1994, The Journal of bone and joint surgery. American volume.